CMS proposes ASP+4% for hospital outpatient drugs
Executive Summary
CMS is proposing to lower the rate at which hospital outpatient drugs are reimbursed from the current average sales price plus 5 percent to ASP plus 4 percent for 2009. According to the outpatient prospective payment system proposed rule for 2009, released July 3, CMS is proposing "to continue our policy of making a combined payment for the acquisition and pharmacy overhead costs of separately payable drugs and biologicals at an equivalent average ASP-based amount calculated based on our standard methodology of estimating drug costs from claims." The agency added that ASP plus 4 percent "is the best currently available proxy for average hospital acquisition cost and associated pharmacy overhead cost.
You may also be interested in...
Increase In Pay For Part B Hospital Outpatient Drugs Needed, Groups Tell CMS
CMS' proposal to drop Medicare Part B drug reimbursement to average sales price plus 4 percent in the hospital outpatient setting is being met with calls for the agency to return to ASP plus 6 percent, the same rate physicians are reimbursed for drugs administered in their offices
Eleven Drugs Lose Medicare Part B Pass-Through Status In 2009 Proposal
CMS will issue its annual proposed changes to the list of drugs and biologicals designated as "pass-through" products under Medicare Part B, with 11 losing that status for 2009, 10 remaining on the list, and no drugs added
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.